ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain Pathology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bpa.12364PMID 26833422PMCID PMC8029305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential nuclear ATRX expression in sarcomas

  2016influential reference
• Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

  2015cited by this paper
• International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

  2014cited by this paper
• ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

  2014influential reference
• Molecular and Morphologic Correlates of the Alternative Lengthening of Telomeres Phenotype in High‐Grade Astrocytomas

  2013cited by this paper
• ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

  2013cited by this paper
• The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas

  2013influential reference
• Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

  2012influential reference
• Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

  2012influential reference
• DAXX envelops a histone H3.3–H4 dimer for H3.3-specific recognition

  2012cited by this paper
• Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

  2012influential reference
• VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

  2012cited by this paper
• Characterization of Molecular Genetic Alterations in GBMs Highlights a Distinctive Molecular Profile in Young Adults

  2011cited by this paper
• DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

  2011cited by this paper
• ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome.

  2011cited by this paper
• Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin

  2011cited by this paper
• Altered Telomeres in Tumors with ATRX and DAXX Mutations

  2011influential reference
• Distinct factors control histone variant H3.3 localization at specific genomic regions.

  2010cited by this paper
• Loss of Maternal ATRX Results in Centromere Instability and Aneuploidy in the Mammalian Oocyte and Pre-Implantation Embryo

  2010cited by this paper
• Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres

  2010cited by this paper
• Protein Complex of Drosophila ATRX/XNP and HP1a Is Required for the Formation of Pericentric Beta-heterochromatin in Vivo*

  2010cited by this paper
• Loss of ATRX leads to chromosome cohesion and congression defects

  2008cited by this paper
• The Chromatin Remodelling Factor dATRX Is Involved in Heterochromatin Formation

  2008influential reference
• Genetic pathways to primary and secondary glioblastoma.

  2007cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• A Novel Transcription Regulatory Complex Containing Death Domain-associated Protein and the ATR-X Syndrome Protein*

  2004cited by this paper
• ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome.

  1996cited by this paper
• Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).

  1995cited by this paper

• Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update

  2025cites this paper
• The Role of Vimentin, Synaptophysin, and Histone H3 Lysine 27 Methylation (H3K27me) as Surrogate Markers in the Diagnosis and Classification of Oligodendrogliomas and Diffuse Midline Gliomas: A Comprehensive Review

  2025cites this paper
• FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair

  2024cites this paper
• A fusion model integrating magnetic resonance imaging radiomics and deep learning features for predicting alpha-thalassemia X-linked intellectual disability mutation status in isocitrate dehydrogenase–mutant high-grade astrocytoma: a multicenter study

  2024cites this paper
• Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma

  2023cites this paper
• Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition

  2023cites this paper
• Alpha Thalassemia/Intellectual Disability Syndrome X-Linked Expression Varies Significantly between Androgen Receptor-Positive and Androgen Receptor-Negative Prostatic Adenocarcinoma: Relation to Epidermal Growth Factor Receptor Expression and Clinicopathological Factors

  2023cites this paper
• ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors

  2022cites this paper
• Diffuse astrocytoma with mosaic IDH1-R132H-mutant immuno-phenotype and low subclonal allele frequency.

  2022cites this paper
• DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis

  2022cites this paper
• Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines

  2022cites this paper
• Pathology, Molecular Biology and Classification of Gliomas

  2021cites this paper
• Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology

  2021cites this paper
• Diffuse midline glioma with H3 K27M mutation of the spinal cord: A series of 33 cases

  2021cites this paper
• Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma

  2020cites this paper
• ATRX immunohistochemistry can help refine ‘not elsewhere classified’ categorisation for grade II/III gliomas

  2019cites this paper
• Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion

  2018cites this paper
• Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature

  2018cites this paper
• Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST

  2018cites this paper
• The Role of ATRX in Glioma Biology

  2017cites this paper